top of page
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Merck | Apr
DMC Biotechnologies appoints James Flatt as CEO to drive growth in sustainable biomanufacturing
Business

DMC Biotechnologies appoints James Flatt as CEO to drive growth in sustainable biomanufacturing

DMC Biotechnologies, a player in the synthetic biology and precision fermentation sectors, has appointed James (Jim) Flatt as its new CEO.

DMC Biotechnologies

The Cell Base is your one-stop shop for all cell-based news – helping you keep your finger on the pulse with the latest business updates and technological insights.

bottom of page